| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | LZ | Common Stock | Tax liability | -$131K | -16.9K | -2.42% | $7.73 | 683K | Nov 15, 2024 | Direct | F1 |
| transaction | LZ | Common Stock | Award | $0 | +608K | +89.04% | $0.00 | 1.29M | Nov 15, 2024 | Direct | F2 |
| holding | LZ | Common Stock | 13.6K | Nov 15, 2024 | By Bryant-Stibel Fund I LLC | F3 | |||||
| holding | LZ | Common Stock | 294K | Nov 15, 2024 | By Escondido Children's Trust | F3 | |||||
| holding | LZ | Common Stock | 538K | Nov 15, 2024 | By Travron Trust | F3 | |||||
| holding | LZ | Common Stock | 2.81M | Nov 15, 2024 | By CES 2020 Trust | F3 | |||||
| holding | LZ | Common Stock | 2.81M | Nov 15, 2024 | By JMS 2020 Trust |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | LZ | Performance Rights (November 2024) | Award | $0 | +912K | $0.00 | 912K | Nov 15, 2024 | Common Stock | 912K | Direct | F4, F5, F6 | ||
| transaction | LZ | Performance Rights (July 2024) | Award | $0 | +5.35M | $0.00 | 5.35M | Jul 9, 2024 | Common Stock | 5.35M | Direct | F7, F8 |
| Id | Content |
|---|---|
| F1 | This transaction represents the automatic withholding of shares of the Issuer's common stock upon the vesting of restricted stock units ("RSUs") in order to satisfy the Reporting Person's tax withholding obligations. |
| F2 | Constitutes the RSU portion of the Reporting Person's executive compensation for 2025. The shares of common stock represent time-based RSUs, with each RSU representing a contingent right to receive one share of the Issuer's common stock. The RSUs vest in substantially equal quarterly installments over a three-year period, with the first vesting date being May 15, 2025, subject to the Reporting Person's continuous service with the Issuer on each such vesting date. |
| F3 | The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of all of the reported securities for purposes of Section 16 or for any other purpose. |
| F4 | Constitutes the performance stock unit portion of the Reporting Person's executive compensation for 2025. Performance vesting is tied to stock price in order to more closely align management with long-term stockholder goals and stock performance. Each performance unit represents a contingent right to receive one share of the Issuer's common stock. The performance units may vest, if at all, between 75% and 400% of the target grant date value ("GDV") based on the stock price targets achieved during a 3-year performance period (subject to a 29-trading day extension in certain circumstances). The number of performance units reported above assumes the maximum stock price target is achieved, resulting in 400% of the GDV becoming eligible to vest. Stock price targets will be achieved based on the volume weighted average closing price of the Issuer's common stock during a consecutive 30-day trading period. |
| F5 | Due to a 1,000 character limit, Footnote 5 is a continuation of Footnote 4: In the first year of the performance period, regardless of whether there is certification of achievement of a stock price target, the performance units will not vest before November 15, 2025, subject to the Reporting Person's continued employment through the vesting date. In the second and third years of the performance period, the performance units will vest immediately upon certification of achievement of a stock price target, subject to the Reporting Person's continued employment through the vesting date. |
| F6 | Subject to a 29-trading day extension in certain circumstances. |
| F7 | On July 10, 2024, the Reporting Person filed a Form 4 inadvertently reporting these performance rights in Table I. This Form 4 restates the previously reported performance rights in Table II instead. |
| F8 | Subject to a 44-trading day extension in certain circumstances. |